These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [A 44-year review on cholangitis and cholelithiasis]. Ran RT; Zhong DC Zhonghua Yi Xue Za Zhi; 1983 Mar; 63(3):129-32. PubMed ID: 6409369 [No Abstract] [Full Text] [Related]
5. Primary sclerosing cholangitis, a vanishing bile duct disease. van Berge Henegouwen GP Neth J Med; 1987 Aug; 31(1-2):27-35. PubMed ID: 3658059 [No Abstract] [Full Text] [Related]
6. [Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis)]. ; ; Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):5-13. PubMed ID: 26983384 [No Abstract] [Full Text] [Related]
7. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis. Sherlock S Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193 [TBL] [Abstract][Full Text] [Related]
8. An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis. Burman BE; Jhaveri MA; Kowdley KV Clin Liver Dis; 2017 Nov; 21(4):709-723. PubMed ID: 28987258 [TBL] [Abstract][Full Text] [Related]
9. Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. Beuers U; Gershwin ME; Gish RG; Invernizzi P; Jones DE; Lindor K; Ma X; Mackay IR; Parés A; Tanaka A; Vierling JM; Poupon R J Hepatol; 2015 Nov; 63(5):1285-7. PubMed ID: 26385765 [No Abstract] [Full Text] [Related]
10. [Recommendations for diagnosis and treatment of primary biliary cholangitis in China (2021)]. Zhang FC; Wang L; Shuai ZW; Wu ZB; Zhang W; Zhang ZL; Lin J; Zhao Y Zhonghua Nei Ke Za Zhi; 2021 Aug; 60(8):709-715. PubMed ID: 34304446 [TBL] [Abstract][Full Text] [Related]
11. [Chronic suppurative cholangitis in biliary cirrhosis caused by a rare variant of the portal vein]. Lazarov B; Makaveeva V; Angelov G Khirurgiia (Sofiia); 1966; 19(1):90-5. PubMed ID: 5947964 [No Abstract] [Full Text] [Related]
12. Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets. Carbone M; Milani C; Gerussi A; Ronca V; Cristoferi L; Invernizzi P J Hepatol; 2020 Oct; 73(4):965-966. PubMed ID: 32709365 [No Abstract] [Full Text] [Related]
13. [Recommendations of APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis]. Chen S; Duan WJ; You H; Ma X; Jia JD Zhonghua Gan Zang Bing Za Zhi; 2022 Feb; 30(2):196-198. PubMed ID: 35359070 [TBL] [Abstract][Full Text] [Related]
14. Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases. Lindor KD; Bowlus CL; Boyer J; Levy C; Mayo M Hepatology; 2022 Apr; 75(4):1012-1013. PubMed ID: 34431119 [No Abstract] [Full Text] [Related]
15. [An interpretation of 2017 EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis]. Han Y; Chen Y Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):814-818. PubMed ID: 29325274 [TBL] [Abstract][Full Text] [Related]
16. Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!". Bowlus CL; Levy C; Hirschfield GM J Hepatol; 2022 Nov; 77(5):1452-1453. PubMed ID: 35977610 [No Abstract] [Full Text] [Related]